Vishnupriya
London: Amid the burgeoning demand of skin care products across the globe South Korea’s injectable aesthetic injectables market is set to grow at an annual growth rate of 12 per cent through 2033 backed by the advantage of advanced formulations, as per a market-analytics firm GlobalData.
According to a GlobalData report, having progressed in adopting advanced formulations to support skin health, the aesthetic injectables market of South Korea will grow at a compound annual growth rate (CAGR) of around 12 per cent through 2033, according to GlobalData, a leading data and analytics company.
As of 2024, South Korea holds around 13 per cent of the Asia-Pacific aesthetic injectables market share and their share is likely to move up on the back of increasing emphasis on achieving natural and youthful aesthetics that will create a high demand for innovative solutions in skin rejuvenation where the country’s Industry is much more advanced than the other relative regions.
Commenting on this development, Aditi Dakshesh Parikh, Medical Devices analyst, GlobalData, said, “South Korea is poised to maintain its influence in the global injectables market by introducing solutions that emphasize sustainable skin health and rejuvenation.”
“With ongoing advancements, the industry’s efforts are expected to center on creating products that offer comprehensive benefits while aligning with the dynamic preferences of today’s consumers,” Parikh added.
